Uncovering the unmet needs among psoriasis patients in the Asia‐Pacific region
Studies on the psychosocial and emotional burden of psoriasis have been extensive; however, there is limited knowledge and awareness of patients’ attitude and behavior towards psoriasis treatment. To understand psoriasis patients’ attitude and behavior towards treatment of psoriasis, especially thos...
Gespeichert in:
Veröffentlicht in: | Journal of dermatology 2021-11, Vol.48 (11), p.1665-1674 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1674 |
---|---|
container_issue | 11 |
container_start_page | 1665 |
container_title | Journal of dermatology |
container_volume | 48 |
creator | Tada, Yayoi Jo, Seong Jin Huang, Yu‐Huei Wahking, Bryan Lee, Bong Young Gowindah, Regina Fernández‐Peñas, Pablo |
description | Studies on the psychosocial and emotional burden of psoriasis have been extensive; however, there is limited knowledge and awareness of patients’ attitude and behavior towards psoriasis treatment. To understand psoriasis patients’ attitude and behavior towards treatment of psoriasis, especially those treated with biologics, a multi‐stage study qualitative and quantitative methodology was conducted among psoriasis patients. An online survey was conducted with 45 moderate‐to‐severe psoriasis patients each in Australia, Japan, South Korea, and Taiwan for 20 min. This was followed by qualitative in‐depth interviews conducted among psoriasis patients in Australia (n = 3) and Japan (n = 2) for 60 min. All of the findings were workshopped with key opinion leaders and patient advisory groups to identify potential solutions addressing patients’ unmet needs. Five common insights were identified across the region, highlighting patients’ attitude and behavior towards psoriasis treatment, especially for those treated with biologics. These insights comprised the following: (i) one of the key factors driving patients’ treatment choice included their ability to enjoy clear skin for longer period (68%); (ii) bio‐maintenance patients had a higher expectation (4.9 months) of how long their skin could stay clear, compared to their pre‐biologics initiation days (2.9 months); (iii) once a good response is achieved, bio‐maintenance patients were more concerned about symptoms returning (44%) than development of side‐effects (19%); (iv) bio‐maintenance patients felt psychologically and physically affected during flare‐ups despite being on more efficacious treatment; and (v) bio‐maintenance patients still felt they were at risk of flare‐ups (4.5/7), almost similar risk perception as non‐biologics patients (4.9/7). Findings from this study showed that psoriasis patients look for treatment with the least risk of flare‐ups so that they were able to enjoy clear skin for a long time. |
doi_str_mv | 10.1111/1346-8138.16072 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9290722</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2555968903</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4682-2d6472435ba9d4e39d162272fc1622a26e61c6a22a314c6de8ca94e30a1c9b073</originalsourceid><addsrcrecordid>eNqFkb1OwzAUhS0EglKYWSOxsAT8FydekBD_CAkGmC3XuS1GiV3spIiNR-AZeRKcFiHBgpdrXX_n6F4fhPYIPiTpHBHGRV4RVh0SgUu6hkY_nXU0wqwqcspxuYW2Y3zGmMqC4E20xTgjFZflCN0_OuMXEKybZd0TZL1rocscQB0z3frUnUcfrI42ZnPdWXBdzKxbsifR6s_3j3tt7NSaLMDMereDNqa6ibD7Xcfo8eL84fQqv727vD49uc0NFxXNaS14STkrJlrWHJisiaC0pFMzVE0FCGKETldGuBE1VEbLxGFNjJzgko3R8cp33k9aqE0aLOhGzYNtdXhTXlv1-8XZJzXzCyWpTD9Fk8HBt0HwLz3ETrU2Gmga7cD3UdGiKKSoJGYJ3f-DPvs-uLReoiSuJCNyMDxaUSb4GANMf4YhWA1pqSEbNWSjlmklRbFSvNoG3v7D1c3Z-Ur3BU7blag</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2590893192</pqid></control><display><type>article</type><title>Uncovering the unmet needs among psoriasis patients in the Asia‐Pacific region</title><source>Wiley Journals</source><creator>Tada, Yayoi ; Jo, Seong Jin ; Huang, Yu‐Huei ; Wahking, Bryan ; Lee, Bong Young ; Gowindah, Regina ; Fernández‐Peñas, Pablo</creator><creatorcontrib>Tada, Yayoi ; Jo, Seong Jin ; Huang, Yu‐Huei ; Wahking, Bryan ; Lee, Bong Young ; Gowindah, Regina ; Fernández‐Peñas, Pablo</creatorcontrib><description>Studies on the psychosocial and emotional burden of psoriasis have been extensive; however, there is limited knowledge and awareness of patients’ attitude and behavior towards psoriasis treatment. To understand psoriasis patients’ attitude and behavior towards treatment of psoriasis, especially those treated with biologics, a multi‐stage study qualitative and quantitative methodology was conducted among psoriasis patients. An online survey was conducted with 45 moderate‐to‐severe psoriasis patients each in Australia, Japan, South Korea, and Taiwan for 20 min. This was followed by qualitative in‐depth interviews conducted among psoriasis patients in Australia (n = 3) and Japan (n = 2) for 60 min. All of the findings were workshopped with key opinion leaders and patient advisory groups to identify potential solutions addressing patients’ unmet needs. Five common insights were identified across the region, highlighting patients’ attitude and behavior towards psoriasis treatment, especially for those treated with biologics. These insights comprised the following: (i) one of the key factors driving patients’ treatment choice included their ability to enjoy clear skin for longer period (68%); (ii) bio‐maintenance patients had a higher expectation (4.9 months) of how long their skin could stay clear, compared to their pre‐biologics initiation days (2.9 months); (iii) once a good response is achieved, bio‐maintenance patients were more concerned about symptoms returning (44%) than development of side‐effects (19%); (iv) bio‐maintenance patients felt psychologically and physically affected during flare‐ups despite being on more efficacious treatment; and (v) bio‐maintenance patients still felt they were at risk of flare‐ups (4.5/7), almost similar risk perception as non‐biologics patients (4.9/7). Findings from this study showed that psoriasis patients look for treatment with the least risk of flare‐ups so that they were able to enjoy clear skin for a long time.</description><identifier>ISSN: 0385-2407</identifier><identifier>EISSN: 1346-8138</identifier><identifier>DOI: 10.1111/1346-8138.16072</identifier><identifier>PMID: 34318497</identifier><language>eng</language><publisher>Tokyo: Wiley Subscription Services, Inc</publisher><subject>Biological products ; biologics ; flare‐ups ; Health behavior ; Health psychology ; Original ; Patient compliance ; Patients ; Psoriasis ; psoriasis treatment ; quality of life ; Skin</subject><ispartof>Journal of dermatology, 2021-11, Vol.48 (11), p.1665-1674</ispartof><rights>2021 The Authors. The published by John Wiley & Sons Australia, Ltd on behalf of Japanese Dermatological Association</rights><rights>2021. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4682-2d6472435ba9d4e39d162272fc1622a26e61c6a22a314c6de8ca94e30a1c9b073</citedby><cites>FETCH-LOGICAL-c4682-2d6472435ba9d4e39d162272fc1622a26e61c6a22a314c6de8ca94e30a1c9b073</cites><orcidid>0000-0003-4882-1564 ; 0000-0001-6016-8209</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2F1346-8138.16072$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2F1346-8138.16072$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>230,314,780,784,885,1417,27924,27925,45574,45575</link.rule.ids></links><search><creatorcontrib>Tada, Yayoi</creatorcontrib><creatorcontrib>Jo, Seong Jin</creatorcontrib><creatorcontrib>Huang, Yu‐Huei</creatorcontrib><creatorcontrib>Wahking, Bryan</creatorcontrib><creatorcontrib>Lee, Bong Young</creatorcontrib><creatorcontrib>Gowindah, Regina</creatorcontrib><creatorcontrib>Fernández‐Peñas, Pablo</creatorcontrib><title>Uncovering the unmet needs among psoriasis patients in the Asia‐Pacific region</title><title>Journal of dermatology</title><description>Studies on the psychosocial and emotional burden of psoriasis have been extensive; however, there is limited knowledge and awareness of patients’ attitude and behavior towards psoriasis treatment. To understand psoriasis patients’ attitude and behavior towards treatment of psoriasis, especially those treated with biologics, a multi‐stage study qualitative and quantitative methodology was conducted among psoriasis patients. An online survey was conducted with 45 moderate‐to‐severe psoriasis patients each in Australia, Japan, South Korea, and Taiwan for 20 min. This was followed by qualitative in‐depth interviews conducted among psoriasis patients in Australia (n = 3) and Japan (n = 2) for 60 min. All of the findings were workshopped with key opinion leaders and patient advisory groups to identify potential solutions addressing patients’ unmet needs. Five common insights were identified across the region, highlighting patients’ attitude and behavior towards psoriasis treatment, especially for those treated with biologics. These insights comprised the following: (i) one of the key factors driving patients’ treatment choice included their ability to enjoy clear skin for longer period (68%); (ii) bio‐maintenance patients had a higher expectation (4.9 months) of how long their skin could stay clear, compared to their pre‐biologics initiation days (2.9 months); (iii) once a good response is achieved, bio‐maintenance patients were more concerned about symptoms returning (44%) than development of side‐effects (19%); (iv) bio‐maintenance patients felt psychologically and physically affected during flare‐ups despite being on more efficacious treatment; and (v) bio‐maintenance patients still felt they were at risk of flare‐ups (4.5/7), almost similar risk perception as non‐biologics patients (4.9/7). Findings from this study showed that psoriasis patients look for treatment with the least risk of flare‐ups so that they were able to enjoy clear skin for a long time.</description><subject>Biological products</subject><subject>biologics</subject><subject>flare‐ups</subject><subject>Health behavior</subject><subject>Health psychology</subject><subject>Original</subject><subject>Patient compliance</subject><subject>Patients</subject><subject>Psoriasis</subject><subject>psoriasis treatment</subject><subject>quality of life</subject><subject>Skin</subject><issn>0385-2407</issn><issn>1346-8138</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>WIN</sourceid><recordid>eNqFkb1OwzAUhS0EglKYWSOxsAT8FydekBD_CAkGmC3XuS1GiV3spIiNR-AZeRKcFiHBgpdrXX_n6F4fhPYIPiTpHBHGRV4RVh0SgUu6hkY_nXU0wqwqcspxuYW2Y3zGmMqC4E20xTgjFZflCN0_OuMXEKybZd0TZL1rocscQB0z3frUnUcfrI42ZnPdWXBdzKxbsifR6s_3j3tt7NSaLMDMereDNqa6ibD7Xcfo8eL84fQqv727vD49uc0NFxXNaS14STkrJlrWHJisiaC0pFMzVE0FCGKETldGuBE1VEbLxGFNjJzgko3R8cp33k9aqE0aLOhGzYNtdXhTXlv1-8XZJzXzCyWpTD9Fk8HBt0HwLz3ETrU2Gmga7cD3UdGiKKSoJGYJ3f-DPvs-uLReoiSuJCNyMDxaUSb4GANMf4YhWA1pqSEbNWSjlmklRbFSvNoG3v7D1c3Z-Ur3BU7blag</recordid><startdate>202111</startdate><enddate>202111</enddate><creator>Tada, Yayoi</creator><creator>Jo, Seong Jin</creator><creator>Huang, Yu‐Huei</creator><creator>Wahking, Bryan</creator><creator>Lee, Bong Young</creator><creator>Gowindah, Regina</creator><creator>Fernández‐Peñas, Pablo</creator><general>Wiley Subscription Services, Inc</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>WIN</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-4882-1564</orcidid><orcidid>https://orcid.org/0000-0001-6016-8209</orcidid></search><sort><creationdate>202111</creationdate><title>Uncovering the unmet needs among psoriasis patients in the Asia‐Pacific region</title><author>Tada, Yayoi ; Jo, Seong Jin ; Huang, Yu‐Huei ; Wahking, Bryan ; Lee, Bong Young ; Gowindah, Regina ; Fernández‐Peñas, Pablo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4682-2d6472435ba9d4e39d162272fc1622a26e61c6a22a314c6de8ca94e30a1c9b073</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Biological products</topic><topic>biologics</topic><topic>flare‐ups</topic><topic>Health behavior</topic><topic>Health psychology</topic><topic>Original</topic><topic>Patient compliance</topic><topic>Patients</topic><topic>Psoriasis</topic><topic>psoriasis treatment</topic><topic>quality of life</topic><topic>Skin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tada, Yayoi</creatorcontrib><creatorcontrib>Jo, Seong Jin</creatorcontrib><creatorcontrib>Huang, Yu‐Huei</creatorcontrib><creatorcontrib>Wahking, Bryan</creatorcontrib><creatorcontrib>Lee, Bong Young</creatorcontrib><creatorcontrib>Gowindah, Regina</creatorcontrib><creatorcontrib>Fernández‐Peñas, Pablo</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Wiley Online Library (Open Access Collection)</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tada, Yayoi</au><au>Jo, Seong Jin</au><au>Huang, Yu‐Huei</au><au>Wahking, Bryan</au><au>Lee, Bong Young</au><au>Gowindah, Regina</au><au>Fernández‐Peñas, Pablo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Uncovering the unmet needs among psoriasis patients in the Asia‐Pacific region</atitle><jtitle>Journal of dermatology</jtitle><date>2021-11</date><risdate>2021</risdate><volume>48</volume><issue>11</issue><spage>1665</spage><epage>1674</epage><pages>1665-1674</pages><issn>0385-2407</issn><eissn>1346-8138</eissn><abstract>Studies on the psychosocial and emotional burden of psoriasis have been extensive; however, there is limited knowledge and awareness of patients’ attitude and behavior towards psoriasis treatment. To understand psoriasis patients’ attitude and behavior towards treatment of psoriasis, especially those treated with biologics, a multi‐stage study qualitative and quantitative methodology was conducted among psoriasis patients. An online survey was conducted with 45 moderate‐to‐severe psoriasis patients each in Australia, Japan, South Korea, and Taiwan for 20 min. This was followed by qualitative in‐depth interviews conducted among psoriasis patients in Australia (n = 3) and Japan (n = 2) for 60 min. All of the findings were workshopped with key opinion leaders and patient advisory groups to identify potential solutions addressing patients’ unmet needs. Five common insights were identified across the region, highlighting patients’ attitude and behavior towards psoriasis treatment, especially for those treated with biologics. These insights comprised the following: (i) one of the key factors driving patients’ treatment choice included their ability to enjoy clear skin for longer period (68%); (ii) bio‐maintenance patients had a higher expectation (4.9 months) of how long their skin could stay clear, compared to their pre‐biologics initiation days (2.9 months); (iii) once a good response is achieved, bio‐maintenance patients were more concerned about symptoms returning (44%) than development of side‐effects (19%); (iv) bio‐maintenance patients felt psychologically and physically affected during flare‐ups despite being on more efficacious treatment; and (v) bio‐maintenance patients still felt they were at risk of flare‐ups (4.5/7), almost similar risk perception as non‐biologics patients (4.9/7). Findings from this study showed that psoriasis patients look for treatment with the least risk of flare‐ups so that they were able to enjoy clear skin for a long time.</abstract><cop>Tokyo</cop><pub>Wiley Subscription Services, Inc</pub><pmid>34318497</pmid><doi>10.1111/1346-8138.16072</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0003-4882-1564</orcidid><orcidid>https://orcid.org/0000-0001-6016-8209</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0385-2407 |
ispartof | Journal of dermatology, 2021-11, Vol.48 (11), p.1665-1674 |
issn | 0385-2407 1346-8138 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9290722 |
source | Wiley Journals |
subjects | Biological products biologics flare‐ups Health behavior Health psychology Original Patient compliance Patients Psoriasis psoriasis treatment quality of life Skin |
title | Uncovering the unmet needs among psoriasis patients in the Asia‐Pacific region |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T02%3A06%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Uncovering%20the%20unmet%20needs%20among%20psoriasis%20patients%20in%20the%20Asia%E2%80%90Pacific%20region&rft.jtitle=Journal%20of%20dermatology&rft.au=Tada,%20Yayoi&rft.date=2021-11&rft.volume=48&rft.issue=11&rft.spage=1665&rft.epage=1674&rft.pages=1665-1674&rft.issn=0385-2407&rft.eissn=1346-8138&rft_id=info:doi/10.1111/1346-8138.16072&rft_dat=%3Cproquest_pubme%3E2555968903%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2590893192&rft_id=info:pmid/34318497&rfr_iscdi=true |